Benjamin D. Hopkins

8.5k citations

44 papers · 4.5k indexed · 2 hit papers · h-index 26

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 4
Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 16
- Metabolism, Diabetes, and Cancer 7
- Protein Kinase Regulation and GTPase Signaling 4
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 3
- Angiogenesis and VEGF in Cancer 3
Genetics top 2%
Oncology top 5%
- Cancer-related Molecular Pathways 4
Cell Biology top 5%

Co-authors: Lewis C. Cantley Honyin Chiu Shubha Bagrodia Robert T. Abraham Marcus D. Goncalves Ramon Parsons Cindy Hodakoski Sarah M. Mense
Cited by: Cancer Research Molecular Biology Genetics
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Benjamin D. Hopkins

39 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
2017 The PI3K Pathway in Human Disease

Peers

Countries citing papers authored by Benjamin D. Hopkins

Since Specialization

Citations

This map shows the geographic impact of Benjamin D. Hopkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin D. Hopkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin D. Hopkins more than expected).

Fields of papers citing papers by Benjamin D. Hopkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin D. Hopkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin D. Hopkins. The network helps show where Benjamin D. Hopkins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin D. Hopkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin D. Hopkins Line = papers co-authored together Benjamin D. Hopkins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma Yang Tian,Reshmee Bhattacharya,Seungyeul Yoo,Feng Jiang,Eric Park,Genesis Lara Granados,Yudao Shen,Kwang‐Su Park,H. Ümit Kanıskan,Jian Jin,Benjamin D. Hopkins,Jun Zhu,Hideo Watanabe	2025	0
2	INTRAVESICAL MUC16 TARGETING CAR T CELLS FOR ORGAN-CONFINED BLADDER CANCERS Parwiz Abrahimi,Jonathan Khan,Alyssa Duren-Lubanski,Winson Cai,Yacine Marouf,Jacob E. Tallman,Bishoy M. Faltas,Hikmat Al‐Ahmadie,Olivier Elemento,Benjamin D. Hopkins,Douglas S. Scherr,Renier J. Brentjens,Jedd D. Wolchok,Taha Merghoub	2025	0
3	The role of biomarkers in the management of HPV-related oropharyngeal cancer Benjamin D. Hopkins,James E. Bates	2025	0
4	Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models Petros A. Tyrakis,Domen Kampjut,G Steele,H. Jonathan G. Lindström,Deborah Chirnomas,Benjamin D. Hopkins,Marcus D. Goncalves,Siddhartha Mukherjee,Lewis C. Cantley,Oliver D.K. Maddocks	2025	2
5	PI3K drives the de novo synthesis of coenzyme A from vitamin B5 Christian C. Dibble,Samuel A. Barritt,Grace E. Perry,Evan C. Lien,Renee C. Geck,Sarah DuBois-Coyne,David Bartee,Thomas Zengeya,Emily B. Cohen,Min Yuan,Benjamin D. Hopkins,Jordan L. Meier,John G. Clohessy,John M. Asara,Lewis C. Cantley,Alex Toker	2022	56
6	Patient-Derived In Vitro and In Vivo Models of Cancer Sally Claridge,Julie‐Ann Cavallo,Benjamin D. Hopkins	2022	7
7	Occipital Headache Evaluation and Rates of Migraine Assessment, Diagnosis, and Treatment in Patients Receiving Greater Occipital Nerve Blocks in an Academic Pain Clinic Shawn Love,Benjamin D. Hopkins,Christopher Migdal,Nathaniel M. Schuster	2022	3
8	Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy Viswajit Kandula,Parth Shah,Vineeth Thirunavu,Ketan Yerneni,Constantine L. Karras,Zachary A. Abecassis,Benjamin D. Hopkins,Orin Bloch,Matthew B. Potts,Babak S. Jahromi,Matthew C. Tate	2022	3
9	A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients Chantal Pauli,Lamberto De Boni,Jonathan E. Pauwels,Yanjiang Chen,Lara Planas‐Paz,Reid Shaw,Brooke M. Emerling,Carla Grandori,Benjamin D. Hopkins,Mark A. Rubin	2021	5
10	Precision Targeting of pten-Null Triple-Negative Breast Tumors Guided by Electrophilic Metabolite Sensing Xuyu Liu,Marcus J. C. Long,Benjamin D. Hopkins,Chaosheng Luo,Lingxi Wang,Yimon Aye	2020	25
11	PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism Diana G. Wang,Marcia N. Paddock,Mark R. Lundquist,Janet Sun,Oksana Mashadova,Solomon Amadiume,Timothy W. Bumpus,Cindy Hodakoski,Benjamin D. Hopkins,Matthew Fine,Amanda A. Hill,Tong Yang,Jeremy M. Baskin,Lukas E. Dow,Lewis C. Cantley	2019	40
12	Fenofibrate prevents skeletal muscle loss in mice with lung cancer Marcus D. Goncalves,Seo‐Kyoung Hwang,Chantal Pauli,Charles J. Murphy,Zhe Cheng,Benjamin D. Hopkins,David Wu,Ryan M. Loughran,Brooke M. Emerling,Guoan Zhang,Douglas T. Fearon,Lewis C. Cantley	2018	85
13	Suppression of insulin feedback enhances the efficacy of PI3K inhibitorsbreakdown → Benjamin D. Hopkins,Chantal Pauli,Xing Du,Diana G. Wang,Xiang Li,David Wu,Solomon Amadiume,Marcus D. Goncalves,Cindy Hodakoski,Mark R. Lundquist,Rohan Bareja,Yan Ma,Emily Harris,Andrea Sboner,Himisha Beltran,Mark A. Rubin,Siddhartha Mukherjee,Lewis C. Cantley	2018	481
14	Abstract PR14: PTEN-Long and gemcitabine combination treatment as a therapeutic for pancreatic cancer Roshan A. Ahmed,Benjamin D. Hopkins,Carmine F. Palermo,Stephen A. Sastra,Zachary Rapp,Ramon Parsons,Kenneth P. Olive	2015	2
15	Ten Years in, Afghan Myths Live On Магнус Марсден,Benjamin D. Hopkins	2011	0
16	Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a Barry Fine,Cindy Hodakoski,Susan Koujak,Tao Su,Lao H. Saal,Matthew Maurer,Benjamin D. Hopkins,Megan Keniry,Maria Luisa Sulis,Sarah M. Mense,Hanina Hibshoosh,Ramon Parsons	2009	182
17	Gab2-Mediated Signaling Promotes Melanoma Metastasis Basil A. Horst,Sofia K. Gruvberger-Saal,Benjamin D. Hopkins,Lindsey A. Bordone,Ying Yang,Karen A. Chernoff,Ijeoma Uzoma,V. Schwipper,J. Liebau,Norma J. Nowak,Georg Brunner,David M. Owens,David L. Rimm,Ramon Parsons,Jülide Tok Çelebi	2009	61
18	Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina Jingfang Sun,Benjamin D. Hopkins,Kaoru Tsujikawa,Carole Perruzzi,Irit Adini,Robert A. Swerlick,Paul Börnstein,Jack Lawler,Laura E. Benjamin	2009	44
19	Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability Qi Xue,Benjamin D. Hopkins,Carole Perruzzi,Durga Udayakumar,David Sherris,Laura E. Benjamin	2008	87
20	Anti-VEGF antibody in experimental hepatoblastoma: Suppression of tumor growth and altered angiogenesis Kimberly W. McCrudden,Benjamin D. Hopkins,Jason S. Frischer,Anna Novikov,Jianzhong Huang,Angela Kadenhe,Tamara New,Akiko Yokoi,Darrell J. Yamashiro,Jessica J. Kandel,William Middlesworth	2003	25

About Benjamin D. Hopkins

Benjamin D. Hopkins is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 44 papers that have together received 4.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (16 papers), Metabolism, Diabetes, and Cancer (7 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (940 citations), Molecular Biology (3.0k citations) and Genetics (398 citations). Benjamin D. Hopkins has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Lewis C. Cantley, Honyin Chiu, Shubha Bagrodia, Robert T. Abraham, Marcus D. Goncalves, Ramon Parsons, Cindy Hodakoski, Sarah M. Mense, Douglas Barrows and Laura E. Benjamin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact